HUP0401798A3 - Use of rosuvastatin for preparation of pharmaceutical compositions usable in pre demented states - Google Patents
Use of rosuvastatin for preparation of pharmaceutical compositions usable in pre demented statesInfo
- Publication number
- HUP0401798A3 HUP0401798A3 HU0401798A HUP0401798A HUP0401798A3 HU P0401798 A3 HUP0401798 A3 HU P0401798A3 HU 0401798 A HU0401798 A HU 0401798A HU P0401798 A HUP0401798 A HU P0401798A HU P0401798 A3 HUP0401798 A3 HU P0401798A3
- Authority
- HU
- Hungary
- Prior art keywords
- demented
- rosuvastatin
- states
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title 1
- 229960000672 rosuvastatin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| PCT/SE2002/001911 WO2003032995A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401798A2 HUP0401798A2 (hu) | 2005-01-28 |
| HUP0401798A3 true HUP0401798A3 (en) | 2005-06-28 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401798A HUP0401798A3 (en) | 2001-10-19 | 2002-10-18 | Use of rosuvastatin for preparation of pharmaceutical compositions usable in pre demented states |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (hu) |
| EP (1) | EP1446123A1 (hu) |
| JP (1) | JP2005505605A (hu) |
| KR (1) | KR20040058201A (hu) |
| CN (1) | CN1604780A (hu) |
| AR (1) | AR036891A1 (hu) |
| BR (1) | BR0213434A (hu) |
| CA (1) | CA2463597A1 (hu) |
| CO (1) | CO5580773A2 (hu) |
| HU (1) | HUP0401798A3 (hu) |
| IL (1) | IL161380A0 (hu) |
| IS (1) | IS7218A (hu) |
| MX (1) | MXPA04003631A (hu) |
| NO (1) | NO20041840L (hu) |
| PL (1) | PL369573A1 (hu) |
| RU (1) | RU2004112422A (hu) |
| SE (1) | SE0103509D0 (hu) |
| WO (1) | WO2003032995A1 (hu) |
| ZA (1) | ZA200402844B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2657076A1 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| CA2546701C (en) | 2003-11-24 | 2010-07-27 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| WO2005056534A1 (en) | 2003-12-02 | 2005-06-23 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
| WO2006017357A1 (en) | 2004-07-13 | 2006-02-16 | Teva Pharmaceutical Industries Ltd. | A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
| JP4713574B2 (ja) | 2005-02-22 | 2011-06-29 | テバ ファーマシューティカル インダストリーズ リミティド | ロスバスタチンアルキルエーテルを含まないロスバスタチンおよびその塩およびそれらを製造する方法 |
| EP1805148A2 (en) | 2005-08-16 | 2007-07-11 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Application Discontinuation
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en active Application Filing
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003032995A8 (en) | 2004-06-03 |
| PL369573A1 (en) | 2005-05-02 |
| WO2003032995A1 (en) | 2003-04-24 |
| MXPA04003631A (es) | 2004-07-30 |
| BR0213434A (pt) | 2004-11-09 |
| IL161380A0 (en) | 2004-09-27 |
| NO20041840L (no) | 2004-05-05 |
| CN1604780A (zh) | 2005-04-06 |
| HUP0401798A2 (hu) | 2005-01-28 |
| JP2005505605A (ja) | 2005-02-24 |
| ZA200402844B (en) | 2005-01-24 |
| CO5580773A2 (es) | 2005-11-30 |
| CA2463597A1 (en) | 2003-04-24 |
| EP1446123A1 (en) | 2004-08-18 |
| US20060229321A1 (en) | 2006-10-12 |
| SE0103509D0 (sv) | 2001-10-19 |
| RU2004112422A (ru) | 2005-04-10 |
| KR20040058201A (ko) | 2004-07-03 |
| AR036891A1 (es) | 2004-10-13 |
| IS7218A (is) | 2004-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0400384A3 (en) | Benzamidine derivative and pharmaceutical compositions containing them and their use | |
| HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| HK1083835A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| HUP0401301A3 (en) | Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0401950A3 (en) | Pyrimidine derivatives and pharmaceutical compositions containing that compounds | |
| HUP0401642A3 (en) | Use of staurosporine derivatives for the preparation of pharmaceutical compositions | |
| HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
| IL209444A0 (en) | O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them | |
| EG24848A (en) | Preparation of aminopyrimidine compounds | |
| HK1070285A1 (en) | Pharmaceutical dosage form of amorphous nelfinavirmesylate | |
| EP1458362A4 (en) | PHARMACEUTICAL COMPOSITIONS IN PARTICLE FORM | |
| HUP0402236A3 (en) | Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof | |
| HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
| IL176248A0 (en) | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| HUP0303193A3 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them | |
| HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
| IL159591A0 (en) | Pharmaceutical compositions containing terbinafin and use thereof | |
| GB0108470D0 (en) | Pharmaceutical compositions and their use | |
| HUP0400386A3 (en) | Tablet comprising cetirizine and pseudoephedrine and its use for preparation of pharmaceutical compositions | |
| HUP0303731A3 (en) | Sulfonylguanidines and their use for preparation of pharmaceutical compositions | |
| HUP0401798A3 (en) | Use of rosuvastatin for preparation of pharmaceutical compositions usable in pre demented states | |
| HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof |